MNA
ELV icon

Manning & Napier Advisors’s Elevance Health ELV Stock Holding History

Manning & Napier Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$143M Sell
367,297
-107,904
-23% -$40M 1.83% 20
2026
Q1 		$139M Buy
475,201
+106,775
+29% +$35.1M 1.96% 11
2025
Q4 		$129M Buy
368,426
+344,237
+1,423% +$116M 1.68% 17
2025
Q3 		$7.82M Sell
24,189
-14,025
-37% -$4.36M 0.1% 108
2025
Q2 		$14.9M Buy
38,214
+20,455
+115% +$8.23M 0.18% 87
2025
Q1 		$7.72M Buy
17,759
+8,613
+94% +$3.46M 0.1% 137
2024
Q4 		$3.37M Buy
+9,146
New +$3.83M 0.04% 190

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Manning & Napier Advisors's ELV Position: Q2 2026 in Review

Manning & Napier Advisors reduced its Elevance Health (ELV) stake by 23% in Q2 2026, selling an estimated $40M and leaving 367,297 shares worth $143M. The position accounts for 1.83% of the portfolio, ranked #20.

Manning & Napier Advisors first reported a position in ELV in Q4 2024 and has held it in 7 quarters since. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Manning & Napier Advisors held 367,297 shares of Elevance Health worth $143M as of Q2 2026.
  • Manning & Napier Advisors sold 107,904 Elevance Health shares in Q2 2026, an estimated $40M.
  • Elevance Health made up 1.83% of Manning & Napier Advisors's portfolio in Q2 2026, its #20 holding.
  • Manning & Napier Advisors first reported a position in Elevance Health in Q4 2024 and has held it in 7 quarters since.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Manning & Napier Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.